December 06, 2016
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Saag discusses lesinurad allopurinol extension trials
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WASHINGTON — At the American College of Rheumatology Annual Meeting, Kenneth G. Saag, MD, professor of medicine in the Division of Clinical Immunology and Rheumatology at the University of Alabama at Birmingham, discussed the CLEAR 1 and 2 extension studies of lesinurad and allopurinol combination therapy in patients with gout.
He mentioned the extension data were similar to those of the original study, which demonstrated good efficacy and safety. However, there was a slight rise in serum creatinine levels for some patients.